查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1984049

抗病毒布料市場：2026-2032年全球市場預測（依產品類型、抗病毒技術、布料類型、加工方法、應用、終端用戶產業及通路分類）

Anti-Viral Fabric Market by Product Type, Antiviral Technology, Fabric Type, Treatment Method, Application, End Use Industry, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，抗病毒織物市場價值將達到 42.2 億美元，到 2026 年將成長至 45.8 億美元，到 2032 年將達到 75.1 億美元，複合年成長率為 8.55%。

主要市場統計數據
基準年 2025 42.2億美元
預計年份：2026年 45.8億美元
預測年份：2032年 75.1億美元
複合年成長率 (%) 8.55%

本文全面概述了抗病毒織物技術，並結合公共衛生優先事項、材料科學進步和商業性應用促進因素進行了闡述。

抗病毒布料正逐漸成為紡織科學、公共衛生需求和工業創新交織的關鍵領域。過去十年，對能夠主動去活化病毒顆粒的材料的投資已從小眾的醫療應用轉向更廣泛的商業和消費用途。塗層化學、嵌入式金屬離子和最後加工技術的創新，拓寬了設計師和製造商可選擇的功能範圍。同時，終端用戶除了關注舒適性和耐用性等傳統纖維特性外，也越來越重視其衛生性能。

加工化學、認證要求和供應鏈整合的進步如何重塑抗病毒織物的普及和競爭優勢？

受技術成熟、監管日益嚴格以及消費者行為轉變的推動，抗病毒織物市場格局正在經歷一場變革。抗病毒整合技術的進步，例如金屬離子和緩釋基質的引入，使得織物具備持久的抗病毒性能，即使經過重複使用和洗滌也能保持有效。同時，基於奈米技術的表面處理和聚合物塗層降低了製造商改造現有生產線的門檻。除了這些技術基礎之外，機構對基於紡織品的感染控制也越來越感興趣，尤其是在醫療機構和人員密集的公共場所。

對 2025 年美國關稅變化將給抗病毒織物價值鏈帶來的成本壓力、本地生產獎勵和戰略供應鏈重組進行評估。

美國宣布2025年實施的關稅措施將引入新的因素，增加生產、加工或進口抗病毒織物及相關原料的企業的業務運作複雜性。對特種化學塗料、某些成品紡織品以及用於抗病毒加工的進口組件徵收更高的關稅，可能會推高整個價值鏈的原料成本，從而擠壓利潤空間。對於從海外採購活性成分的垂直整合型製造商而言，這些關稅將促使其將關鍵原料在地化或與供應商重新談判獎勵以減輕關稅負擔。因此，採購團隊正在審查供應商矩陣和總到岸成本模型，以在維持產品品質達標的同時，維持價格競爭力。

對產品類型、抗病毒技術、織物成分、應用、行業買家、加工方法和分銷管道進行詳細的細分映射，以指導策略優先排序。

市場區隔揭示了抗病毒織物創新如何與特定應用性能要求和商業性管道交織在一起。按產品類型分類，市場包括服裝、過濾材料、家居佈置和醫用紡織品。服裝又細分為休閒服、防護衣和運動服；過濾材料分為空氣過濾和水過濾；家居佈置涵蓋床上用品、窗簾和室內裝潢；醫用紡織品包括醫院床單、手術罩衣和創傷護理產品。每種產品層在耐用性、舒適性和監管方面都存在固有的限制，這些限制會影響加工方法和商業化策略的選擇。依抗病毒技術分類，市場可分為「塗層織物」、「嵌入式製劑」和「奈米加工」。塗層織物包括金屬塗層和聚合物塗層；嵌入式製劑包括銅離子和銀離子的應用；奈米加工的特點是採用奈米銅和奈米銀技術。技術選擇會影響性能永續性、可製造性和環境影響。

美洲、歐洲、中東和非洲以及亞太地區等地的需求因素、監管複雜性和製造專業化程度正在影響抗病毒布料的策略。

區域趨勢正在形成差異化的需求模式和政策環境，這將對抗菌布料的應用軌跡產生重大影響。在美洲，大規模機構買家和契約製造正在推動對醫院級解決方案和個人防護設備（PPE）的需求，而注重健康的都市區消費者則促進了日常服裝和家用紡織品領域的創新。該地區供應鏈韌性和近岸外包的趨勢正在推動對國內後整理和檢驗能力的投資，而監管也日益關注性能聲明和環境安全。

在成熟的性能、可靠的供應和永續性透明度的驅動下，競爭動態正在推動整合技術和製造夥伴關係關係的發展。

一群成熟新興企業正透過差異化的技術組合、策略夥伴關係和精準的商業化策略，重塑抗病毒織物市場。領先的化學品供應商正投資研發可融入聚合物基質或透過高效塗層系統賦予抗病毒特性的持久性抗病毒藥物，而紡織品製造商和整理商則在建造檢驗能力，以滿足機構採購要求。專注於最後加工和金屬離子嵌入技術的新興參與企業正在推出可縮短加工時間並提高耐洗性的專用工藝，這迫使成熟企業加快創新和夥伴關係策略的步伐。

領導者可採取切實可行的策略行動，以確保抗病毒藥物的持續有效性、強大的供應鏈、合規的產品標籤以及有針對性的市場進入。

產業領導者應推動一系列合作舉措，以保障利潤率、加速產品普及並降低合規風險。首先，他們應優先投資於檢驗的抗病毒技術，這些技術需兼顧耐用性和環境安全性，並實施獨立測試以增強對採購的信心。其次，他們應調整供應鏈策略，透過供應商多元化、考慮國內加工流程以及與關鍵材料供應商談判長期契約，來降低關稅和原料價格波動風險。第三，他們應設計能反映各通路需求的市場對市場模式。對於企業級產品，他們應優先考慮經銷夥伴和直接交易；而對於消費品，則應充分利用數位化管道和品牌故事。

結合專家訪談、專利和標準審查、技術成熟度評估和供應鏈映射，研究途徑嚴謹的混合方法，可以獲得可靠的見解。

本研究採用綜合分析方法，旨在整合技術、監管和商業性訊號。主要資訊來源包括對材料科學家、表面處理專家、醫療和酒店行業的採購經理以及檢驗化學品安全要求的監管顧問的結構化訪談。二級資訊來源包括關於抗病毒機制的同行評審文獻、展示技術進步的專利申請、已發布的標準和測試方法，以及記錄實施案例的行業白皮書。透過整合這些多元化的訊息，我們識別出持續存在的績效瓶頸、監管轉折點以及買方決策標準。

整合策略挑戰，展示檢驗的抗病毒能力、供應鏈韌性和永續性可靠性如何決定市場領導地位。

總之，抗病毒織物代表著材料科學進步與緊迫的公共衛生和商業性需求相結合的一個機會領域。持久性嵌入式抗菌劑、先進塗層和奈米技術驅動的整理工藝正在拓展其實際應用範圍，使其超越傳統的醫療領域，涵蓋消費服裝、家用紡織品、過濾材料和酒店布草等領域。然而，成功的商業化需要可靠的檢驗、供應鏈的適應性以及對環境影響的考量。監管監測、關稅壓力以及區域製造業發展趨勢的相互作用預計將繼續影響哪些技術和市場進入模式能夠取得成功。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：抗病毒織物市場：依產品類型分類

  • 服飾
    • 休閒裝
    • 防護衣
    • 運動服
  • 過濾介質
    • 空氣過濾
    • 水過濾
  • 內部的
    • 寢具
    • 窗簾
    • 室內裝潢
  • 醫用紡織品
    • 醫院床位
    • 手術罩衣
    • 創傷護理

第9章：抗病毒布料市場：以抗病毒技術分類

  • 塗層織物
    • 金屬塗層
    • 聚合物塗層
  • 植入式藥物
    • 銅離子
    • 銀離子
  • 奈米加工
    • 奈米銅
    • 奈米銀

第10章：抗病毒布料市場：依布料類型分類

  • 混紡布料
    • 聚酯棉
    • 波利烏爾
  • 天然纖維
    • 棉布
    • 羊毛
  • 合成纖維
    • 尼龍
    • 聚酯纖維

第11章：抗病毒織品市場：依處理方法分類

  • 獨特加工
  • 表面處理

第12章：抗病毒織物市場：依應用分類

  • 衛生保健
    • 診所使用
    • 居家醫療
    • 對於醫院
  • 家用紡織品
    • 寢具
    • 窗簾
    • 家具布料
  • 飯店業
    • 寢具
    • 紡織品
    • 制服
  • 個人防護設備
    • 手套
    • 罩衣
    • 面具
  • 運動服
    • 健身
    • 戶外裝備
    • 跑步服

第13章：抗病毒布料市場：依終端用戶產業分類

  • 汽車產業
  • 消費品
  • 醫療領域
  • 飯店業

第14章：抗病毒布料市場：依通路分類

  • 直銷
  • 銷售代理銷售
  • 線上銷售

第15章：抗病毒織物市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章：抗病毒布料市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章：抗病毒布料市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國抗病毒織物市場

第19章：中國抗病毒布料市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Acme Group
  • Aditya Birla Fashion and Retail Limited
  • Albini Group
  • Arvind Ltd.
  • Berger Paints
  • Boyteks
  • Carrington Textiles Ltd.
  • Diesel SpA
  • Donear Industries Ltd.
  • D'Decor Home Fabrics Pvt. Ltd.
  • Grado Lab
  • HealthGuard Corporation Pty. Ltd.
  • HeiQ Materials AG
  • iFabric Corp.
  • Inner Mettle Inc. Ltd.
  • Polygiene Group
  • Raymond Ltd.
  • Rudolf GmbH
  • Shiva Texyarn Limited by Vedanayagam Hospital Private Limited
  • Siyaram Silk Mills Ltd.
  • SQ Group
  • Takisada-Nagoya Co., Ltd.
  • Toray Industries, Inc.
  • Wearwell (UK) Limited
  • Welspun
Product Code: MRR-2E76C3E47F63

The Anti-Viral Fabric Market was valued at USD 4.22 billion in 2025 and is projected to grow to USD 4.58 billion in 2026, with a CAGR of 8.55%, reaching USD 7.51 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.22 billion
Estimated Year [2026] USD 4.58 billion
Forecast Year [2032] USD 7.51 billion
CAGR (%) 8.55%

Comprehensive orientation to antiviral textile technologies contextualized within public health priorities, material science advances, and commercial adoption drivers

Antiviral fabrics are emerging as a critical intersection between textile science, public health imperatives, and industrial innovation. Over the past decade, investment in materials that actively neutralize viral particles has shifted from niche healthcare applications to broader commercial and consumer uses. Innovations in coating chemistries, embedded metallic ions, and nanofinishing techniques have expanded the functional palette available to designers and manufacturers, while end users increasingly prioritize hygiene performance alongside traditional textile attributes such as comfort and durability.

This introduction frames antiviral textile technologies within the broader context of risk mitigation and product differentiation. It highlights the convergence of regulatory scrutiny, consumer expectations, and supply chain modernization that together shape adoption pathways. By examining the underlying material science, treatment methods, and application domains, decision-makers can better understand where antiviral fabrics provide unique value and where conventional solutions remain sufficient. The goal of this section is to orient executive readers toward the strategic levers that influence investment choices and to clarify the technical and commercial criteria that define success in product development and market entry.

How advancements in treatment chemistry, certification expectations, and supply chain integration are reshaping adoption and competitive advantage in antiviral textiles

The landscape for antiviral fabrics is experiencing transformative shifts driven by technological maturation, regulatory tightening, and evolving buyer behavior. Advances in embedded agent approaches, such as metal ion incorporation and controlled-release matrices, are enabling durable antiviral performance that survives repeated use and laundering. Concurrently, nano-enabled surface treatments and polymer coatings have reduced application barriers for manufacturers seeking to retrofit existing production lines. These technological enablers are complemented by growing institutional interest in textile-mediated infection control, particularly in healthcare and high-density public venues.

At the same time, procurement patterns are changing as buyers demand verifiable performance and lifecycle considerations. Certification frameworks and standardized test protocols are emerging to distinguish credible antiviral claims from marketing rhetoric, which in turn influences supplier selection and pricing structures. Supply chain dynamics are also shifting: strategic sourcing of active materials, geographic diversification of finishing capacity, and closer collaboration between chemical suppliers and textile mills have reduced time-to-market for new antiviral products. Together, these shifts are creating new competitive frontiers where speed of validation, durability of treatment, and integrated supply chain capabilities determine who captures long-term value.

Assessment of how the 2025 United States tariff changes create cost pressures, localization incentives, and strategic supply chain reconfiguration for antiviral textile value chains

United States tariff policy announced for 2025 introduces a new vector of operational complexity for companies that produce, finish, or import antiviral fabrics and related inputs. Increased tariffs on specialty chemical coatings, certain finished textile products, and import components used in antiviral finishing can raise input costs and compress margins across the value chain. For vertically integrated manufacturers that source active agents internationally, the tariffs amplify incentives to localize critical supply or to renegotiate supplier agreements to mitigate duty exposure. As a result, procurement teams are reevaluating supplier matrices and total landed cost models to preserve price competitiveness while maintaining product integrity.

Beyond cost impacts, tariffs influence strategic decisions around where to locate finishing capacity and how to structure commercial contracts. Some organizations may accelerate domestic finishing investments to avoid repeated tariff exposure on intermediate goods, while others may redesign products to use alternative antiviral treatment methods that rely on locally sourced materials. Furthermore, tariffs tend to incentivize strategic stockpiling and longer purchasing cycles, which can strain working capital and create planning uncertainty. In this environment, companies that proactively model tariff scenarios, diversify input sources, and engage in cross-border supply chain planning are better positioned to maintain continuity and protect margins.

Detailed segmentation mapping across product categories, antiviral technologies, fabric compositions, applications, industry buyers, treatment methods, and distribution pathways to guide strategic prioritization

Segmentation reveals where antiviral textile innovations intersect with application-specific performance requirements and commercial pathways. Based on Product Type, the market encompasses Apparel, Filtration Material, Home Furnishing, and Medical Textiles, with Apparel subdivided into Casual Wear, Protective Clothing, and Sportswear; Filtration Material differentiated into Air Filtration and Water Filtration; Home Furnishing covering Bedding Products, Curtains, and Upholstery; and Medical Textiles spanning Hospital Bedding, Surgical Gowns, and Wound Care. Each product tier imposes distinct durability, comfort, and regulatory constraints, informing treatment choices and commercialization strategies. Based on Antiviral Technology, the landscape splits among Coated Fabric, Embedded Agent, and Nano Finishing, with Coated Fabric including Metal Coating and Polymer Coating, Embedded Agent covering Copper Ion and Silver Ion implementations, and Nano Finishing featuring Nano Copper and Nano Silver approaches. Technology selection affects performance longevity, manufacturability, and environmental profiles.

Further granularity emerges when considering Fabric Type: Blended Fabric such as Poly Cotton and Poly Wool, Natural Fabric like Cotton and Wool, and Synthetic Fabric including Nylon and Polyester each interact differently with antiviral chemistries, influencing adhesion, hand feel, and wash durability. Based on Application, antiviral fabrics are used across Healthcare, Home Textile, Hospitality, Personal Protection, and Sportswear, with Healthcare differentiated into Clinic Use, Home Healthcare, and Hospital Use; Home Textile into Bedding, Curtains, and Upholstery; Hospitality into Bedding, Textiles, and Uniforms; Personal Protection into Gloves, Gowns, and Masks; and Sportswear into Fitness Wear, Outdoor Gear, and Running Apparel. End Use Industry segmentation highlights Automotive Industry, Consumer Goods, Healthcare Sector, and Hospitality Industry as distinct buyers with unique procurement cycles and performance expectations. Treatment Method segmentation distinguishes Inherent Treatment from Surface Treatment, each offering trade-offs between permanence and retrofit flexibility. Finally, Distribution Channel considerations differentiate Direct Sales, Distributor Sales, and Online Sales, which shape customer engagement, pricing strategy, and post-sale service models.

Taken together, these segmentation lenses provide a multidimensional map that clarifies where technical innovation delivers the greatest commercial leverage, which buyer groups demand the highest certainty of performance, and how product design and go-to-market models should be adapted for each segment. This integrated view helps firms prioritize R&D investment, channel development, and certification efforts to align with segment-specific value propositions.

Regional demand drivers, regulatory complexity, and manufacturing specialization across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping antiviral fabric strategies

Regional dynamics create differentiated demand patterns and policy environments that materially influence adoption trajectories for antiviral fabrics. In the Americas, large institutional buyers and contract manufacturers drive demand for hospital-grade solutions and personal protective equipment, while consumer adoption in high-awareness urban centers pushes innovation toward everyday apparel and home textiles. Supply chain resilience and nearshoring trends in this region encourage investment in domestic finishing and validation capacity, and regulatory scrutiny is increasingly focused on performance claims and environmental safety.

Europe, Middle East & Africa presents a mosaic of regulatory frameworks and procurement behaviors. Strong sustainability mandates and rigorous chemical safety standards in many European markets place a premium on treatments that balance antiviral efficacy with eco-toxicological credentials. In the Middle East and Africa, demand is often event-driven and tied to government procurement cycles, though rapid infrastructure projects and hospitality sector growth are creating localized opportunities. Across this combined region, companies must navigate a complex interplay of certification regimes, sustainability reporting expectations, and heterogeneous purchasing protocols.

Asia-Pacific remains a central hub for textile manufacturing and finishing innovation, with integrated supply chains and advanced chemical processing capabilities that support rapid iteration of antiviral treatments. High-volume production capabilities and close proximity to raw material suppliers make this region a focal point for both technology development and cost-competitive manufacturing. However, rising labor costs and stricter environmental enforcement in key manufacturing countries are prompting investment in cleaner chemistries and more efficient finishing processes. Understanding these regional nuances is essential for firms seeking to align production footprint, regulatory compliance, and go-to-market timing across global portfolios.

Competitive dynamics driven by validated performance, supply reliability, and sustainability transparency that favor integrated technology and manufacturing partnerships

A set of incumbent and emerging companies are shaping the antiviral fabric landscape through differentiated technology portfolios, strategic partnerships, and targeted commercialization approaches. Leading chemical suppliers are investing in durable antiviral agents that can be integrated into polymer matrices or delivered via robust coating systems, while textile mills and finishers are building validation capabilities to meet institutional procurement requirements. New entrants focused on nanofinishing and metallic ion embedding are introducing specialized processes that reduce processing time and improve wash durability, forcing legacy players to accelerate innovation and partnership strategies.

Competition increasingly centers on three axes: performance validation, supply chain reliability, and sustainability transparency. Firms that can demonstrate reproducible antiviral efficacy under standardized test conditions, sustain supply of active materials, and provide clear environmental and safety data gain preferential access to large institutional contracts. Collaboration between chemical innovators, fabric manufacturers, and independent testing bodies is becoming a differentiator, as integrated value chains reduce time to market and lower technical risk for buyers. For buyers looking to enter or scale in this market, the competitive landscape favors partners who offer both technical credibility and the logistical infrastructure to support certification, large-scale finishing, and after-sale documentation.

Practical strategic actions for leaders to secure durable antiviral performance, resilient supply chains, compliant product claims, and targeted go-to-market execution

Industry leaders should pursue a coordinated set of actions that protect margins, accelerate adoption, and reduce compliance risk. First, prioritize investments in validated antiviral technologies that balance durability with environmental safety, and pursue independent testing to support procurement confidence. Second, align supply chain strategies to mitigate tariff exposure and input volatility by diversifying suppliers, exploring domestic finishing options, and negotiating longer-term agreements with key material providers. Third, design go-to-market models that reflect channel-specific needs: prioritize distribution partnerships and direct engagement for institutional buyers, while leveraging digital channels and brand storytelling for consumer-facing products.

In addition, leaders should integrate sustainability metrics into product development and commercial narratives to address regulatory trends and buyer expectations. Investing in lifecycle assessments and transparent chemical disclosure reduces procurement friction and differentiates offerings in tender processes. Finally, build cross-functional teams that bring together R&D, regulatory affairs, procurement, and commercial strategy to ensure that product claims are defensible, manufacturable at scale, and aligned with customer purchasing behaviors. These coordinated actions will increase the likelihood of successful product launches and sustainable market presence.

Rigorous mixed-method research approach combining expert interviews, patent and standards review, technology readiness evaluation, and supply chain mapping for robust insights

This research synthesis draws on a multi-method approach designed to triangulate technological, regulatory, and commercial signals. Primary inputs include structured interviews with material scientists, finishing specialists, procurement leaders in healthcare and hospitality, and regulatory consultants who monitor chemical safety requirements. Secondary sources encompass peer-reviewed literature on antiviral mechanisms, patent filings that reveal technology trajectories, publicly available standards and test methods, and industry white papers that document implementation case studies. These diverse inputs are synthesized to identify persistent performance constraints, regulatory inflection points, and buyer decision criteria.

Analytical methods include technology readiness assessments to evaluate durability and manufacturability, supply chain mapping to understand sourcing risk and tariff exposure, and competitive benchmarking to identify differentiators in validation and sustainability. Where possible, findings are corroborated across multiple data streams to reduce single-source bias. Throughout the research process, attention is paid to verifiability of antiviral claims, environmental and safety considerations, and the operational implications of scaling treatments from pilot to high-volume production. This methodology ensures that recommendations are grounded in both technical realities and commercial practicability.

Synthesis of strategic imperatives showing how validated antiviral performance, supply chain resilience, and sustainability credentials determine market leadership

In conclusion, antiviral fabrics represent an opportunity space where material science advances intersect with pressing public health and commercial needs. Durable embedded agents, sophisticated coatings, and nano-enabled finishes have broadened the set of feasible applications beyond traditional healthcare use cases into consumer apparel, home textiles, filtration media, and hospitality linens. However, successful commercialization requires credible validation, supply chain adaptability, and attention to environmental profiles. The interplay of regulatory scrutiny, tariff pressures, and regional manufacturing dynamics will continue to shape which technologies and go-to-market models succeed.

Organizations that combine validated performance data with resilient sourcing strategies and transparent sustainability credentials will have a decisive advantage. As adoption accelerates in targeted segments, early movers who invest in certification, local finishing capacity where needed, and clear communication of trade-offs between durability and environmental impact will be best positioned to capture institutional and premium consumer demand. Ultimately, antiviral fabrics will become another vector through which textile manufacturers demonstrate value, but the winners will be those who can reliably deliver verified performance at scale while managing the commercial and regulatory complexities that define this evolving market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Anti-Viral Fabric Market, by Product Type

  • 8.1. Apparel
    • 8.1.1. Casual Wear
    • 8.1.2. Protective Clothing
    • 8.1.3. Sportswear
  • 8.2. Filtration Material
    • 8.2.1. Air Filtration
    • 8.2.2. Water Filtration
  • 8.3. Home Furnishing
    • 8.3.1. Bedding Products
    • 8.3.2. Curtains
    • 8.3.3. Upholstery
  • 8.4. Medical Textiles
    • 8.4.1. Hospital Bedding
    • 8.4.2. Surgical Gowns
    • 8.4.3. Wound Care

9. Anti-Viral Fabric Market, by Antiviral Technology

  • 9.1. Coated Fabric
    • 9.1.1. Metal Coating
    • 9.1.2. Polymer Coating
  • 9.2. Embedded Agent
    • 9.2.1. Copper Ion
    • 9.2.2. Silver Ion
  • 9.3. Nano Finishing
    • 9.3.1. Nano Copper
    • 9.3.2. Nano Silver

10. Anti-Viral Fabric Market, by Fabric Type

  • 10.1. Blended Fabric
    • 10.1.1. Poly Cotton
    • 10.1.2. Poly Wool
  • 10.2. Natural Fabric
    • 10.2.1. Cotton
    • 10.2.2. Wool
  • 10.3. Synthetic Fabric
    • 10.3.1. Nylon
    • 10.3.2. Polyester

11. Anti-Viral Fabric Market, by Treatment Method

  • 11.1. Inherent Treatment
  • 11.2. Surface Treatment

12. Anti-Viral Fabric Market, by Application

  • 12.1. Healthcare
    • 12.1.1. Clinic Use
    • 12.1.2. Home Healthcare
    • 12.1.3. Hospital Use
  • 12.2. Home Textile
    • 12.2.1. Bedding
    • 12.2.2. Curtains
    • 12.2.3. Upholstery
  • 12.3. Hospitality
    • 12.3.1. Bedding
    • 12.3.2. Textiles
    • 12.3.3. Uniforms
  • 12.4. Personal Protection
    • 12.4.1. Gloves
    • 12.4.2. Gowns
    • 12.4.3. Masks
  • 12.5. Sportswear
    • 12.5.1. Fitness Wear
    • 12.5.2. Outdoor Gear
    • 12.5.3. Running Apparel

13. Anti-Viral Fabric Market, by End Use Industry

  • 13.1. Automotive Industry
  • 13.2. Consumer Goods
  • 13.3. Healthcare Sector
  • 13.4. Hospitality Industry

14. Anti-Viral Fabric Market, by Distribution Channel

  • 14.1. Direct Sales
  • 14.2. Distributor Sales
  • 14.3. Online Sales

15. Anti-Viral Fabric Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Anti-Viral Fabric Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Anti-Viral Fabric Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Anti-Viral Fabric Market

19. China Anti-Viral Fabric Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Acme Group
  • 20.6. Aditya Birla Fashion and Retail Limited
  • 20.7. Albini Group
  • 20.8. Arvind Ltd.
  • 20.9. Berger Paints
  • 20.10. Boyteks
  • 20.11. Carrington Textiles Ltd.
  • 20.12. Diesel S.p.A.
  • 20.13. Donear Industries Ltd.
  • 20.14. D'Decor Home Fabrics Pvt. Ltd.
  • 20.15. Grado Lab
  • 20.16. HealthGuard Corporation Pty. Ltd.
  • 20.17. HeiQ Materials AG
  • 20.18. iFabric Corp.
  • 20.19. Inner Mettle Inc. Ltd.
  • 20.20. Polygiene Group
  • 20.21. Raymond Ltd.
  • 20.22. Rudolf GmbH
  • 20.23. Shiva Texyarn Limited by Vedanayagam Hospital Private Limited
  • 20.24. Siyaram Silk Mills Ltd.
  • 20.25. SQ Group
  • 20.26. Takisada-Nagoya Co., Ltd.
  • 20.27. Toray Industries, Inc.
  • 20.28. Wearwell (UK) Limited
  • 20.29. Welspun

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANTI-VIRAL FABRIC MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANTI-VIRAL FABRIC MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY ANTIVIRAL TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FABRIC TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY TREATMENT METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES ANTI-VIRAL FABRIC MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA ANTI-VIRAL FABRIC MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CASUAL WEAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CASUAL WEAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CASUAL WEAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PROTECTIVE CLOTHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PROTECTIVE CLOTHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PROTECTIVE CLOTHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY AIR FILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY AIR FILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY AIR FILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WATER FILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WATER FILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WATER FILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CURTAINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CURTAINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CURTAINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UPHOLSTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UPHOLSTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UPHOLSTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITAL BEDDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITAL BEDDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITAL BEDDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SURGICAL GOWNS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SURGICAL GOWNS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SURGICAL GOWNS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WOUND CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WOUND CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY ANTIVIRAL TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY METAL COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY METAL COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY METAL COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLYMER COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLYMER COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLYMER COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COPPER ION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COPPER ION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COPPER ION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SILVER ION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SILVER ION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SILVER ION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO COPPER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO COPPER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO COPPER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO SILVER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO SILVER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO SILVER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLY COTTON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLY COTTON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLY COTTON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLY WOOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLY WOOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLY WOOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COTTON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COTTON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COTTON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WOOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WOOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WOOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY INHERENT TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY INHERENT TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY INHERENT TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SURFACE TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SURFACE TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SURFACE TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CLINIC USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CLINIC USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CLINIC USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITAL USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITAL USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CURTAINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CURTAINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CURTAINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UPHOLSTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UPHOLSTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UPHOLSTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY TEXTILES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY TEXTILES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY TEXTILES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UNIFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UNIFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UNIFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY GLOVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY GLOVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY GLOVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY GOWNS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY GOWNS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY GOWNS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY MASKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY MASKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY MASKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FITNESS WEAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FITNESS WEAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FITNESS WEAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY OUTDOOR GEAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY OUTDOOR GEAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY OUTDOOR GEAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY RUNNING APPAREL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY RUNNING APPAREL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY RUNNING APPAREL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY AUTOMOTIVE INDUSTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY AUTOMOTIVE INDUSTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY AUTOMOTIVE INDUSTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CONSUMER GOODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CONSUMER GOODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CONSUMER GOODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE SECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE SECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE SECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY INDUSTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY INDUSTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY INDUSTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 211. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 212. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, 2018-2032 (USD MILLION)
  • TABLE 214. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 215. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, 2018-2032 (USD MILLION)
  • TABLE 216. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, 2018-2032 (USD MILLION)
  • TABLE 217. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY ANTIVIRAL TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 219. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, 2018-2032 (USD MILLION)
  • TABLE 220. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, 2018-2032 (USD MILLION)
  • TABLE 221. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 223. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, 2018-2032 (USD MILLION)
  • TABLE 224. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, 2018-2032 (USD MILLION)
  • TABLE 225. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 226. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 228. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 229. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, 2018-2032 (USD MILLION)
  • TABLE 230. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 231. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, 2018-2032 (USD MILLION)
  • TABLE 232. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 233. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, 2018-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 238. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, 2018-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, 2018-2032 (USD MILLION)
  • TABLE 240. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY ANTIVIRAL TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 242. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, 2018-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, 2018-2032 (USD MILLION)
  • TABLE 244. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 246. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, 2018-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, 2018-2032 (USD MILLION)
  • TABLE 248. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 252. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, 2018-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 254. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, 2018-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 256. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, 2018-2032 (USD MILLION)
  • TABLE 260. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, 2018-2032 (USD MILLION)
  • TABLE 262. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, 2018-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY ANTIVIRAL TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 264. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, 2018-2032 (USD MILLION)
  • TABLE 266. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, 2018-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, 2018-2032 (USD MILLION)
  • TABLE 270. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, 2018-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 272. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 274. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, 2018-2032 (USD MILLION)
  • TABLE 276. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, 2018-2032 (USD MILLION)
  • TABLE 278. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY ANTIVIRAL TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, 2018-2032 (USD MILLION)
  • TABLE 306. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 307. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, 2018-2032 (USD MILLION)
  • TABLE 308. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY ANTIVIRAL TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, 2018-2032 (USD MILLION)
  • TABLE 317. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 318. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 319. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 320. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 321. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, 2018-2032 (USD MILLION)
  • TABLE 322. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 323. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, 2018-2032 (USD MILLION)
  • TABLE 324. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 325. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 326. MIDDLE EAST ANTI-VIRAL FABRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 327. MIDDLE EAST ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. MIDDLE EAST ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, 2018-2032 (USD MILLION)
  • TABLE 329. MIDDLE EAST ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 330. MIDDLE EAST ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, 2018-203